Target Name: KRT6B
NCBI ID: G3854
Review Report on KRT6B Target / Biomarker Content of Review Report on KRT6B Target / Biomarker
KRT6B
Other Name(s): Cytokeratin-6B | Keratin, epidermal, type II, K6B | PC4 | Keratin, type II cytoskeletal 6B | Keratin-6B | type-II keratin Kb10 | Keratin 6B | K6B | Cytokeratin 6B | Type-II keratin Kb10 | keratin-like 1 (a type II keratin sequence) | KRTL1 | keratin, epidermal, type II, K6B | keratin 6B, type II | keratin 6B | Keratin-like 1 (a type II keratin sequence) | K2C6B_HUMAN | CK6B | cytokeratin 6B | CK-6B | PC2

KRT6B: A Protein Involved in Cell Regulation and Drug Targeting

KRT6B (Cytokeratin-6B) is a protein that is expressed in a variety of tissues throughout the body, including the skin, hair, nails, and connective tissue. It is a member of the keratin family, which is a group of proteins that are found in the skin, hair, and nails. KRT6B is one of the proteins that is known as a cytokeratin, which means that it is composed of a cytoskeleton made of repetitive amino acid residues.

KRT6B is involved in the regulation of many different cellular processes in the body. For example, it is involved in cell growth, differentiation, and adhesion. It is also involved in the development and maintenance of the skin, hair, and nails.

One of the ways that KRT6B is involved in these processes is by regulating the production of cell surface antigens, such as the proteins that are responsible for creating the extracellular matrix (ECM) that supports and gives shape to cells. This is important for many different cell types, including epithelial cells, which are responsible for the formation of the skin and other epithelial tissues.

Another way that KRT6B is involved in these processes is by regulating the production of connective tissue cells, such as tendon cells and fat cells. This is important for maintaining the structure and function of connective tissue, which is important for many different physiological functions, including movement and maintaining posture.

KRT6B is also involved in the regulation of the immune response. For example, it is known to be involved in the development of immune cells, such as natural killer cells and T-cells. It is also involved in the regulation of the production of antibodies , which are proteins that are responsible for fighting off foreign substances in the body.

In addition to its role in cell regulation, KRT6B is also thought to have potential as a drug target. Because it is involved in so many different cellular processes, it is possible that KRT6B could be a useful target for the development of new therapies for a variety of diseases. For example, KRT6B may be a good candidate for a therapy for cancer, as it is involved in the regulation of cell growth and division. It may also be a good candidate for a therapy for autoimmune diseases, as it is involved in the regulation of the immune response.

Overall, KRT6B is a complex protein that is involved in a wide range of cellular processes in the body. It is a potential drug target, with potential for the development of new therapies for a variety of diseases. Further research is needed to fully understand the role of KRT6B in cell regulation and its potential as a drug target.

Protein Name: Keratin 6B

The "KRT6B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT6B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3